Abstract:Objective To investigate the serum levels and clinical significance of osteopontin (OPN) and disintegrin and metalloprotease 8 (ADAMS) in patients with lung cancer.Methods Twenty four patients with small cell lung cancer (SCLC) (SCLC group),60 patients with non-SCLC (NSCLC) (NSCLC group) and 20 healthy volunteers (control group) were detected the serum levels of OPN and ADAM8 by ELISA.The relationship of OPN and ADAM8 with pathological characteristics of NSCLC was analyzed.The efficacy of serum OPN and ADAM8 for diagnosing SCLC and NSCLC was analyzed by ROC curve.Results The expressions of OPN and ADAM8 were significantly higher in NSCLC group ((36.86±11.00) μg/L,(2 695.99±568.86) ng/L) and SCLC group ((35.47±12.01) μg/L,(2 428.82± 415.42) ng/L) than those in control group ((25.45±10.71) μg/L,(1 737.29±594.36) ng/L) (P＜0.05),and there were no significant differences between NSCLC group and SCLC group (P＞0.05).OPN was positively correlated with ADAM8 in NSCCLC group (r=0.440,P=0.001),and there was no linear correlation between OPN and ADAM8 in SCLCgroup and control group (r=0.180,P=0.468;r=0.110,P=0.725).The levels of OPN and ADAM8 were significantly higher in the patients with pathological stage Ⅲ + Ⅳ,lymph node metastasis and distal metastasis than those in the patients with pathological stage Ⅰ + Ⅱ,with no lymph node metastasis or distal metastasis (P＜0.05).When the optimal cut-off value of OPN was 26.73 μg/L,the AUC for diagnosing NSCLC was 0.779 (95％ CI:0.618-0.940,P=0.002),the sensitivity was 86.7％,and the specificity was 66.7％.When the cut-off value of ADAM8 was 1 673.76 ng/L,theAUC for diagnosing NSCLC was 0.869 (95％CI:0.752-0.987,P＜0.001),the sensitivity was 100.0％,and the specificity was 66.7％.When the optimal cut-off value of OPN was 24.50 νg/L,the AUC for diagnosing SCLC was 0.745 (95 ％ CI:0.559-0.932,P=0.025),the sensitivity was 88.9％,and the specificity was 58.3％.When the cut-off value of ADAM8 was 1 783.50 ng/L,the AUC for diagnosing SCLC was 0.806 (95％CI:0.627-0.984,P=0.005),the sensitivity was 94.4％,and the specificity was 66.7％.Conclusion Both serum OPN and ADAM8 have certain values to the diagnosis of NSCLC and SCLC,and their levels are correlated with the clinicopathological characteristics of NSCLC,therefore they can be used as molecular indexes for disease monitoring and prognosis evaluation of NSCLC.

Track Study in Deoxypyridinoline on Diagnose Osseous Metastasis of Lung Neoplasms

Diagnostic Value of Urinary Pyridol,urinary Deoxypyridinoline and Urinary N Terminal Telopeptide in Cancer Patients with Bone Metastases

Assessment of Liver Metastasis in Patients with GastricCancer Using Contrast-Enhanced Ultrasonography Quantitative Analysis

Application of double contrast-enhanced ultrasonography to access the lymph nodes metastasis of gastric carcinoma

Three Hematological Indexes That May Serve As Prognostic Indicators in Patients with Primary, High-Grade, Appendicular Osteosarcoma

99Tcm-MDP SPECT/CT used in diagnosis of pulmonary metastasis from osteosarcoma

The application of serum N-MID in auxiliary diagnosis and therapeutic effect monitoring of bone metastasis in patients with primary lung cancer

Quantitative assessment of 99mTc-methylene diphosphonate bone SPECT/CT for assessing bone metastatic burden and its prognostic value in patients with castration-resistant prostate cancers: initial results in a single-center retrospective study

Discriminating Patients With Early-Stage Breast Cancer From Benign Lesions By Detection Of Oxidative Dna Damage Biomarker In Urine

Prognostic Significance of Preoperative Serum ALP and LDH in Osteosarcoma Patients

Comparison of 99Mtc-3Prgd2 Integrin Receptor Imaging with 99Mtc-Mdp Bone Scan in Diagnosis of Bone Metastasis in Patients with Lung Cancer: a Multicenter Study.

Study on Diagnostic Value of P1NP and Β-Ctx in Bone Metastasis of Patients with Breast Cancer and the Correlation Between Them.

Expression and significance of osteopontin and disintegrin and metalloprotease 8 in patients with lung cancer

The Plasma Concentration of D-Dimer is Associated with Neoadjuvant-Chemotherapy Efficacy and the Prognosis in Osteosarcoma

Correlation Between PD-L1 Expression and 18F-FDG Uptake in Lung Adenocarcinoma

Application of human urine 8-hydroxy deoxyguanosine detection by HPLC method in clinical tumor diagnosis

Identification of a biomarker to predict doxorubicin/cisplatin chemotherapy efficacy in osteosarcoma patients using primary, recurrent and metastatic specimens

Correlation of PET/CT Standardized Uptake Value and Lactic Dehydrogenase, Β2-Microglobulin and Ki-67 Positive Rate in Non-Hodgkin's Lymphoma

Standardized uptake valuemax of the primary lesion combined with tumor markers for clinically predicting distant metastasis in de novo lung adenocarcinoma

Added value of spectral parameters for the assessment of lymph node metastasis of lung cancer with dual-layer spectral detector computed tomography

Circulating exosomal PD-L1 at initial diagnosis predicts outcome and survival of patients with osteosarcoma